Page last updated: 2024-08-18

fluorodeoxyuridylate and Hepatocellular Carcinoma

fluorodeoxyuridylate has been researched along with Hepatocellular Carcinoma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	2 (66.67)	2.80

Authors

Authors	Studies
Chang, J; Jiang, J; Kang, J; Li, E; Li, L; Liu, B; Peng, Y; Wang, Q; Wang, Y; Wu, J; Yang, Q; Yu, W; Zhang, J	1
Guo, J; Huang, L	1
Guo, J; Huang, L; Liu, Y; Sun, D; Yu, Z; Zou, Y	1

Reviews

1 review(s) available for fluorodeoxyuridylate and Hepatocellular Carcinoma

Article	Year
Formulation of two lipid-based membrane-core nanoparticles for FOLFOX combination therapy. Nature protocols, 2022, Volume: 17, Issue:8 Topics: Animals; Carcinoma, Hepatocellular; Colorectal Neoplasms; Fluorodeoxyuridylate; Fluorouracil; Lipids; Liposomes; Liver Neoplasms; Nanoparticles; Oxaliplatin; Polyethylene Glycols	2022

Other Studies

2 other study(ies) available for fluorodeoxyuridylate and Hepatocellular Carcinoma

Article	Year
Discovery of an Orally Active and Liver-Targeted Prodrug of 5-Fluoro-2'-Deoxyuridine for the Treatment of Hepatocellular Carcinoma. Journal of medicinal chemistry, 2016, 04-28, Volume: 59, Issue:8 Topics: Administration, Oral; Animals; Antineoplastic Agents; Area Under Curve; Carcinoma, Hepatocellular; Deoxyuridine; Drug Discovery; Liver; Liver Neoplasms, Experimental; Mice; Prodrugs; Rats; Rats, Sprague-Dawley; Tissue Distribution	2016
Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma. Molecular cancer, 2021, 01-06, Volume: 20, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carcinoma, Hepatocellular; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Drug Compounding; Drug Synergism; Female; Fluorodeoxyuridylate; Fluorouracil; Immunogenic Cell Death; Immunotherapy; Leucovorin; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasm Metastasis; Organoplatinum Compounds; Reactive Oxygen Species; Tissue Distribution	2021

Article

Year

Discovery of an Orally Active and Liver-Targeted Prodrug of 5-Fluoro-2'-Deoxyuridine for the Treatment of Hepatocellular Carcinoma.

Journal of medicinal chemistry, 2016, 04-28, Volume: 59, Issue:8

Topics: Administration, Oral; Animals; Antineoplastic Agents; Area Under Curve; Carcinoma, Hepatocellular; Deoxyuridine; Drug Discovery; Liver; Liver Neoplasms, Experimental; Mice; Prodrugs; Rats; Rats, Sprague-Dawley; Tissue Distribution

2016

Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma.

Molecular cancer, 2021, 01-06, Volume: 20, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carcinoma, Hepatocellular; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Drug Compounding; Drug Synergism; Female; Fluorodeoxyuridylate; Fluorouracil; Immunogenic Cell Death; Immunotherapy; Leucovorin; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Neoplasm Metastasis; Organoplatinum Compounds; Reactive Oxygen Species; Tissue Distribution

2021